FK-866 ≥98% (by NMR)

Supplier: ENZO LIFE SCIENCES AG

Synonyms: (E)-N-(4-(1-Benzoylpiperidin-4-yl)butyl)-3-(pyridin-3-yl)acrylamide, (E)-Daporinad

ALX270501M001 ALX270501M005
ENZOALX270501M001EA 141.9 EUR
ENZOALX270501M001 ENZOALX270501M005
FK-866 ≥98% (by NMR)
FK-866

Nampt inhibitor


Selective inhibitor of the nicotinamide pathway dependent NAD+synthesis, causing NAD+ depletion. Highly specific, non-competitive inhibitor of nicotinamide phosphoribosyltransferase (NAMPT/NAPRT) for both the enzyme/substrate complex and the free enzyme (Ki=0.4 nM and Ki´=0.3 nM, respectively). NAD+ depletion by FK-866 directs delayed cell death by apoptosis in Hep-G2 human liver carcinoma cells (IC50=~1 nM). Causes premature senescence in normal human smooth muscle cells. Induces autophagy in SH-SY5Y neuroblastoma cells, as indicated by the formation of LC3-positive vesicles.


Synthetic.

Formula: C₂₄H₂₉N₃O₂
MW: 391,5 g/mol
MDL Number: MFCD10565943
CAS Number: 658084-64-1

Order Now

Learn more

About VWR

Avantor is a vertically integrated, global supplier of discovery-to-delivery solutions for...

Learn more About VWR